BiotechTube
Home/CellTrans/James McGarrigle, PhD
JM

James McGarrigle, PhD

Chief Operating Officer

CellTrans

Therapeutic Areas

Type 1 Diabetes

CellTrans Pipeline

DrugIndicationPhase
LANTIDRA (donislecel-jujn)Type 1 Diabetes with severe hypoglycemiaApproved

Leadership Team at CellTrans

JO
José Oberholzer, MD
Founder, President & Chief Medical Officer
GL
Giovanna La Monica, PhD
Chief Quality Officer
PR
Peter Rios, PhD
Chief Scientific Officer
View full CellTrans profile